Home > > Pharmaceuticals and Healthcare > > Celiac Disease Treatment Market Trends, Size, Share, Growth and Forecast Report by 2032
Celiac Disease Treatment Market - Size, Share, Industry Trends, and Forecasts (2025-2032)
ID : CBI_2520 | Updated on : | Author : Yogesh K | Category : Pharmaceuticals and Healthcare
Celiac Disease Treatment Market Size:
Celiac Disease Treatment Market size is growing with a CAGR of 11.2% during the forecast period (2025-2032), and the market is projected to be valued at USD 1,626.47 Million by 2032 from USD 698.40 Million in 2024. Additionally, the market value for the 2025 attributes to USD 774.08 Million.
- North America accounted for the highest Celiac Disease Treatment Market 2024 share at 39.88% and was valued at USD 278.52 Million.
- North America Celiac Disease Treatment Market expected to reach USD 606.94 Million in 2032.
- U.S. accounted for the Celiac Disease Treatment Market share of 71.34% during the base year of 2024.
- Asia Pacific Celiac Disease Treatment Market is experiencing the fastest growth with a CAGR of 13.5%.
Celiac Disease Treatment Market Scope & Overview:
Celiac disease is an autoimmune disorder with gluten indigestibility. Gluten is a type of protein found in grains such as wheat, rye, and barley amongst others. When people with celiac disease eat gluten, their immune system attacks intestine. This makes it hard for their body to absorb nutrients. This leads to digestive issues, fatigue, weight loss, and long-term health problems. It is caused by a combination of genetics and environmental factors. Medical professionals guide patients to a strict glute-free diet, which is the main celiac disease treatment. Some vitamins and supplements are prescribed. There are no specific medications to treat celiac disease. However, there are drugs and enzymes that help with symptoms and inflammation. Hospitals and clinics amongst others are healthcare facilities where this disease is treated.
Celiac Disease Treatment Market Dynamics - (DRO) :
Key Drivers:
The Rising Prevalence of Celiac Disease is Accelerating the Market
Celiac disease is an autoimmune disorder. It prevents the body from absorbing nutrients from gluten. This disease is treated mainly with a gluten-free diet. This helps in healing the small intestine. Nutritional supplements are also provided to patients to replace any serious deficiencies. Drugs and enzymes therapies reduce inflammation and help in digesting gluten. Increased awareness and changes in wheat consumption have led to the rising prevalence of celiac disease.
For instance,
- According to an article published by Experience Life, in 2023, over the past few decades, there has been a consistent annual increase of 7.5% in the number of new celiac disease diagnoses. This has increased the demand for treatment, thus driving the market share.
Overall, the rising prevalence of celiac disease is significantly boosting market growth.
Growing Support from Advocacy Groups and Government is Driving the Celiac Disease Treatment Market Expansion.
Celiac disease is a serious health problem and if effects millions of people globally. Many patients worldwide remain undiagnosed due to lack of awareness and financial restraints. Owing to this, organizations such as Celiac Disease Foundation and Beyond Celiac are working to educate people. Governments are also launching various groups to help the celiac patient community to address the existing issues.
For instance,
- In 2021, U.S. government launched Congressional Celiac Disease Caucus bipartisan group. They are raising awareness through campaigns and are providing financial assistance to patients. This has increased the visits for celiac disease treatment, thus driving the industry.
Thus, growing support from advocacy groups and governments is accelerating the global celiac disease treatment market growth.
Key Restraints:
High Cost of Gluten-free Foods is Hampering the Celiac Disease Treatment Market Demand
People with celiac disease or gluten sensitivity need to avoid gluten. This is important to prevent health problems such as digestive issues, nutrient deficiencies, and an increased risk of certain cancers. However, gluten-free foods are much more expensive than regular foods.
For instance,
- According to an article published by Coeliac UK, in 2024, compared to normal food, gluten free versions such as bread loaves are 4.5x, plain flour 2x, bread rolls 3.1x, pasta 2x, crackers 1.7x, and cereals 2.1x more expensive.
Moreover, most health insurance plans do not cover gluten-free foods. This means patients pay for everything out of pocket. This increases their financial burden. Hence, the high costs of gluten-free foods and lack of insurance for it are hampering the celiac disease treatment market demand.
Future Opportunities :
Development of Novel Therapies is Expected to Increase Celiac Disease Treatment Market Opportunities.
Currently, the only way to manage celiac disease is by following a strict gluten-free diet. However, even with careful eating, accidental gluten exposure in the stomach causes serious health problems. This is why scientists and pharmaceutical companies are developing new drug treatment which are specific to celiac condition. This includes both drugs-based therapies and enzyme-based therapies.
For instance,
- Entero Therapeutic’s potential drug latiglutenase for celiac disease has entered clinical phase 3. It is a mixture of enzymes that breaks down gluten into harmless fragments. This creates potential for the market.
Overall, development of novel therapies is expected to increase celiac disease treatment market opportunities.
Celiac Disease Treatment Market Segmental Analysis :
By Treatment Type:
Based on treatment type, the market is categorized into gluten-free diet, vitamin & mineral supplements, medical therapies, and others.
Trends in Treatment Type:
- Research is exploring the role of gut microbiota in celiac disease. This is leading to increased interest in probiotics and prebiotics to support gut health and potentially reduce symptoms.
- Development of more effective and stable enzymes is degrading gluten in the digestive tract. This aims to provide relief from accidental gluten exposure.
The gluten-free diet segment accounted for the largest market share in 2024.
- Gluten-free diet segment dominated the celiac disease treatment market trends. A gluten-free diet is a dietary restriction. This excludes foods which contain gluten protein found in cereals.
- This is helping the damaged villi in the small intestine to heal. It restores nutrient absorption. It also improves symptoms such as abdominal pain, diarrhea, and fatigue.
- Increasing awareness of celiac disease has led to rising demand for gluten-free foods. To cater this, manufacturers are launching more products.
- For instance, in 2024, Feel Good Foods launched gluten-free chicken soup dumplings. They are a convenient, microwaveable option for lunch, dinner, or a snack.
- Overall, as per the market analysis, the new product launches are driving a segment in celiac disease treatment market growth.
The medical therapies segment is expected to grow at the fastest CAGR over the forecast period.
- Medical therapies is an emerging segment in market trends. It is further categorized into drug therapy and enzyme therapy.
- Immunotherapy and anti-inflammatory are the drugs which are helpful in blocking the immune system’s overreaction to gluten.
- Some monoclonal antibodies are in development to reduce gut inflammation.
- Moreover, special enzymes are helping in breaking down gluten before it reaches the small intestine. This reduces the risk of damage.
- These therapies also lower the health risks such as osteoporosis and malnutrition.
- According to market analysis, ongoing research into novel pharmaceutical therapies will drive segment for the upcoming years.
By End Use:
Based on end-use, the market is categorized into hospitals, clinics, and others.
Trends in the End-Use:
- Diagnosis of celiac disease is becoming more efficient. Owing to this, celiac disease treatment is shifting to specialized outpatient clinics, reducing the burden on hospitals.
- The use of telehealth platforms is expanding in hospitals. This is enabling remote consultations and dietary guidance in rural areas.
The hospitals segment accounted for the largest market share of 56.23% in 2024.
- Hospitals segment dominated the celiac disease treatment market trends. They play a crucial role in managing initial phases of the disease.
- They are equipped with advanced equipment required for accurate diagnosis such as endoscopy and biopsies. This helps doctors to make proper treatment decisions.
- Campaigns, educational programs, and blogs from healthcare organizations, government bodies, and patient advocacy groups are increasing awareness.
- For instance, Houston Methodist, published an article in 2024 stating what is celiac disease, how it is diagnosed, and how patients can manage it. This has increased the number of visits to hospitals regarding diagnosis and treatment purposes.
- Overall, as per the market analysis, growing awareness is driving segmental growth in the celiac disease treatment industry.
The clinics segment is expected to grow at the fastest CAGR over the forecast period.
- The clinics segment is emerging in market trends. They offer outpatient services.
- This includes providing diagnostic, preventative, and treatment services without requiring overnight stays.
- Moreover, one key reason for their growth is increased accessibility. Clinics are in urban and semi-urban areas. This makes them convenient for patients who do not need the comprehensive care provided by hospitals.
- Additionally, they are becoming hubs for seminars and counseling sessions. This is helping patients adhere to a gluten-free diet.
- Also, these clinics have started operating in rural areas. This addresses the growing demand for healthcare services.
- Thus, according to market analysis, the shift towards outpatient care and preventive medicine will drive the segment for the forecasted years.
Regional Analysis:
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest celiac disease treatment market share at 39.88% and was valued at USD 278.52 Million and is expected to reach USD 606.94 Million in 2032. In North America, the U.S. accounted for the celiac disease treatment market share of 71.34% during the base year of 2024. Genetics factors, diet, gastrointestinal infections, stress, have led to an increase in cases of celiac disease in the region.
- For instance, according to an article published by University of Pennsylvania, in 2025, more than 3 million people are affected with celiac disease in the U.S. This growing patient population is driving market growth for celiac disease treatment.
Moreover, there is an expansion of online pharmacies. This is making it easier for celiac patients to access gluten-free foods. Many patients prefer online shopping because it offers a wider range of gluten-free products and home delivery options. Overall, rising celiac disease cases and online pharmacies are leading to the celiac disease treatment market expansion in the region.
In Asia Pacific, the celiac disease treatment market is experiencing the fastest growth with a CAGR of 13.5% over the forecast period. Awareness of celiac disease is increasing in the region. It is due to better education, social media, and healthcare initiatives. More doctors are recognizing symptoms. This is leading to higher treatment rates. Governments and advocacy groups are promoting gluten-free diets. Moreover, Hotels, restaurants, and catering (HoReCa) businesses in APAC are offering more gluten-free options. Many international food chains and luxury hotels are now providing gluten-free menus to attract health-conscious and celiac customers.
Europe's celiac disease treatment market analysis states that several trends are responsible for the progress of the market in the region. European countries are providing financial support for celiac patients. They are reimbursing the cost of gluten-free foods and medical treatments. In countries such as Italy and the UK, patients are receiving subsidies and insurance coverage for necessary products. Moreover, food and pharmaceutical companies in Europe are actively launching new gluten-free products such as breads, snacks, and meals.
The Middle East and Africa (MEA) celiac disease treatment market analysis states that the region is also witnessing several trends for a notable surge. Some countries such as Saudi Arabia, UAE, and South Africa are investing in research for gluten-free foods. Food labeling regulations are also being introduced to help patients manage their condition. This support is driving market growth care. Moreover, more hospitals and clinics in MEA are adopting advanced diagnostic tools for celiac disease.
Latin America's celiac disease treatment market is also emerging. Researchers and pharmaceutical companies are working on new therapies for celiac disease. This includes enzyme-based treatments to help digest gluten. It also includes immunotherapy drugs to reduce the immune reaction. Growing clinical in the region is seeing increased interest in medical solutions beyond just a gluten-free diet. Moreover, Governments, healthcare organizations, and food companies in Latin America are collaborating to improve celiac disease management.
Top Key Players & Market Share Insights:
The Celiac Disease Treatment market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global Celiac Disease Treatment market. Key players in The Celiac Disease Treatment industry include-
- General Mills, Inc. (United States)
- Kraft Heinz (United States)
- Mondelez International Inc (United States)
- Amy's Kitchen (United States)
- Bob's Red Mill (United States)
- Kellanova (United States)
- Hain Celestial Group (United States)
- Schar (Italy)
- Conagra Brands Inc (United States)
- Barilla Group (Italy)
Recent Industry Developments :
Product Launch:
- In October 2024, Feel Good Foods launched gluten-free frozen chicken soup dumplings. They are made with a rice flour wrapper and a filling of chicken, broth, scallions, and ginger.
- In February 2024, Goodles launched gluten-free versions of their macaroni and cheese pasta. The new products are made with corn, brown rice, and chickpea protein.
Celiac Disease Treatment Market Report Insights:
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 1,626.47 Million |
| CAGR (2025-2032) | 11.2% |
| By Treatment Type |
|
| By End-Use |
|
| By Region |
|
| Key Players |
|
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage |
|
Key Questions Answered in the Report
How big is the Celiac Disease Treatment market? +
In 2024, the Celiac Disease Treatment market is USD 698.40 Million.
Which is the fastest-growing region in the Celiac Disease Treatment market? +
Asia Pacific is the fastest-growing region in the Celiac Disease Treatment market.
What specific segmentation details are covered in the Celiac Disease Treatment market? +
Treatment Type and End-Use segmentation details are covered in the Celiac Disease Treatment market
Who are the major players in the Celiac Disease Treatment market? +
General Mills, Inc. (United States), Kraft Heinz (United States), Kellanova (United States), Hain Celestial Group (United States), Dr. Schar (Italy), and Conagra Brands Inc (United States) are some major players in the market.